OKYO Pharma Announces Purchase of Shares by Chairman
Chairman Gabriele Cerrone increased his stake in OKYO Pharma by purchasing 22,500 shares at $1.45 per share through Panetta Partners Ltd. The purchase brings his total holding to 10,873,916 ordinary shares, representing 20.55% of the company's issued share capital.
Key figures
- Drug Name
- urcosimod
- Phase Of Trial
- Phase 3
- Total holding
- 10873916
- Purchase price
- 1.45
- Shares purchased
- 22500
- Ownership percent
- 20.55%
- Patient enrollment
- 111
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.